Wordt geladen...
Rosuvastatin Decreases Intestinal Fatty Acid Binding Protein (I-FABP), but Does Not Alter Zonulin or Lipopolysaccharide Binding Protein (LBP) Levels, in HIV-Infected Subjects on Antiretroviral Therapy
INTRODUCTION: Altered gastrointestinal (GI) barrier integrity and subsequent microbial translocation may contribute to immune activation in HIV infection. We have reported that rosuvastatin improved several markers of immune activation in HIV+ participants, but the effect of statin treatment on mark...
Bewaard in:
| Gepubliceerd in: | Pathog Immun |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Pathogens and Immunity
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4972492/ https://ncbi.nlm.nih.gov/pubmed/27500282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20411/pai.v1i1.124 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|